Related Experiment Videos
[Transdermal use of nitroglycerin]
Folia Medica Cracoviensia
|January 1, 1989
Summary
Transdermal nitroglycerin provides sustained therapeutic levels for ischemic heart disease, improving exercise tolerance and reducing anginal attacks. A 12-hour patch interval is needed to prevent tolerance.
Area of Science:
- Cardiology
- Pharmacology
Context:
- Transdermal nitroglycerin is increasingly used for pharmacotherapy.
- It ensures prolonged therapeutic drug levels in blood serum.
- Clinical experience is extensive in effort angina and other ischemic heart diseases.
Purpose:
- To summarize the efficacy and application of transdermal nitroglycerin.
- To highlight its benefits in various forms of ischemic heart disease.
Summary:
- Transdermal nitroglycerin improves exercise tolerance, increases pain threshold, and delays ECG changes.
- It also reduces anginal attack frequency and benefits hemodynamics in myocardial infarction with heart failure.
- Early results for silent myocardial ischemia are promising.
Impact:
- Transdermal nitroglycerin offers a sustained and effective treatment option for ischemic heart disease.
- Understanding tolerance is key for optimal dosing intervals (12 hours).